These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 20422332)
21. Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability. Badshah A; Subhan F; Rauf K AAPS PharmSciTech; 2010 Sep; 11(3):1397-404. PubMed ID: 20824513 [TBL] [Abstract][Full Text] [Related]
22. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design. Genç L; Jalvand E Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094 [TBL] [Abstract][Full Text] [Related]
23. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design. Singh I; Saini V Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096 [TBL] [Abstract][Full Text] [Related]
24. Formulation development of carvedilol compression coated tablet. Shah R; Patel S; Patel H; Pandey S; Shah S; Shah D Pharm Dev Technol; 2013; 18(4):906-15. PubMed ID: 21797662 [TBL] [Abstract][Full Text] [Related]
25. Formulation of aspirin-magaldrate double-layer tablets: in vitro evaluation and cytoprotective activity in rats. al Gohary OM; el Din K; el Tahir H Boll Chim Farm; 1996; 135(7):421-8. PubMed ID: 9035555 [TBL] [Abstract][Full Text] [Related]
26. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose. Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495 [TBL] [Abstract][Full Text] [Related]
27. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability. Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268 [TBL] [Abstract][Full Text] [Related]
28. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118 [TBL] [Abstract][Full Text] [Related]
29. Formulation and in vitro characterization of xanthan gum-based sustained release matrix tables of isosorbide-5- mononitrate. Kar R; Mohapatra S; Bhanja S; Das D; Barik B Iran J Pharm Res; 2010; 9(1):13-9. PubMed ID: 24363701 [TBL] [Abstract][Full Text] [Related]
30. Formulation and evaluation of floating matrix tablet of stavudine. Prajapati PH; Nakum VV; Patel CN Int J Pharm Investig; 2012 Apr; 2(2):83-9. PubMed ID: 23119237 [TBL] [Abstract][Full Text] [Related]
31. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release. Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548 [TBL] [Abstract][Full Text] [Related]
32. Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives. Rebouh S; Lefnaoui S; Bouhedda M; Yahoum MM; Hanini S Drug Deliv Transl Res; 2019 Feb; 9(1):162-177. PubMed ID: 30341764 [TBL] [Abstract][Full Text] [Related]
33. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release. Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164 [TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of Ketoprofen sustained release matrix tablet using Kaleemullah M; Jiyauddin K; Thiban E; Rasha S; Al-Dhalli S; Budiasih S; Gamal OE; Fadli A; Eddy Y Saudi Pharm J; 2017 Jul; 25(5):770-779. PubMed ID: 28725150 [TBL] [Abstract][Full Text] [Related]
35. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns. Jan SU; Khan GM; Hussain I Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990 [TBL] [Abstract][Full Text] [Related]
36. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Ravi PR; Ganga S; Saha RN Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101 [TBL] [Abstract][Full Text] [Related]
37. Mini-tablets as technological strategy for modified release of morphine sulfate. Silva RTCE; Bruschi ML Pharm Dev Technol; 2022 Sep; 27(7):766-772. PubMed ID: 36017971 [TBL] [Abstract][Full Text] [Related]
38. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Barakat NS; Elbagory IM; Almurshedi AS Drug Deliv; 2009 Jan; 16(1):57-65. PubMed ID: 19555310 [TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of 6-mercaptopurine and metoclopramide polypill formulation for oral administration: In-vitro and ex vivo studies. Chowdhary R; Pai RS; Singh G Int J Pharm Investig; 2013 Oct; 3(4):217-24. PubMed ID: 24350042 [TBL] [Abstract][Full Text] [Related]
40. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics. Saravanan M; Sri Nataraj K; Ganesh KS Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]